According to a report published by Grand View Research, Inc.; the vascular grafts market is expected to reach a valuation of USD 3,626 million by 2022. High prevalence of cardiac diseases, diabetes, cardiac aneurysms, hypertension, and Coronary Artery Disease (CAD) can propel the market growth during the forecast period (from 2012 to 2022). In addition, growing healthcare expenditure satisfactory reimbursement policies and development of advanced technological facilities are likely to positively drive the market growth. Increasing demand for biomaterial vascular graft and technological advancements lead to development of innovative products including Nellix and Fortevo can also expected to increase the product demand.
Growing number of incidences regarding Cardiovascular Disease (CVD) treatment failures including failure of surgical reconstruction, organ transplantation, and negative outcomes as a result of mechanical devices are estimated to augment the minimally invasive vascular implant growth. This is likely to boost the vascular grafts market growth during the forecast period. Moreover, high incidence of diabetes and End-stage Renal Diseases (ESRDs) are also expected to drive the market during the next few years. As per international diabetes federation, the number of diabetes patients is likely to increase from 366 million to 552 million in the coming years. The global vascular grafts market can be segmented on the basis of product, application, raw material, and regions.
Full Research Report On Vascular Graft Market Analysis:
https://www.grandviewresearch.com/industry-analysis/vascular-graft-market
On the basis of product, the market can be classified into hemodialysis access graft, coronary artery by-pass graft, endovascular stent graft, and peripheral vascular graft. Technological innovations and product development in the treatment of Peripheral Arterial Disease (PAD) are likely to boost peripheral vascular device demand over the projected period. The spiral flow peripheral vascular graft provides better patency than polytetrafluoroethylene (PTFE) grafts, used for damaged blood vessel reconstruction. On the basis of application, the market can be segregated into cardiovascular diseases, kidney failure, aneurysm, vascular occlusion, and diabetes.
On the basis of raw material, the market can be divided into polytetrafluoroethylene (PTFE)-based vascular graft, polyurethane-based vascular graft, polyester-based vascular graft, and biological materials-based vascular graft. The polyester-based vascular grafts segment held the largest revenue share of 38 % in 2014. Biological material-based grafts segment is estimated to be the leading segment and is a projected to expand at a growth rate of 9.6 % from 2012 to 2022. This growth is credited to the high prevalence of CVDs and reduction in the demand for polymer grafts. Geographically, the market can be divided into North America, Europe, Latin America, Asia Pacific, Middle East and Africa.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices
In 2014, North America captured half of the total market share. This growth can be attributed to increasing cases of CVDs, diabetes, and chronic kidney diseases in this region. Availability of advanced healthcare infrastructure and better reimbursement coverage are also contributing toward the North America vascular grafts market growth. In addition, rising adoption of advanced products to provide better care and advent of new discoveries of specific tissue engineered grafts are also expected to fuel the market development in this region. European region is likely to witness a significant growth during the forecast period due to rising number of research projects regarding biomaterials by the European Union in collaboration with medical organizations.
In addition, growing incidences of CVDs and increasing adoption of prosthetic graft implantation would also spur the product demand in the region. The Asia Pacific regional market for vascular grafts is projected to expand at a growth rate of 10 % during the estimated period. This growth can be associated with the rise in targeted disease such as kidney disorders and CVDs and along with rapidly developing healthcare infrastructure. In addition, supporting government efforts such as the “Make In India” campaign is motivating major companies in the market to start their manufacturing facilities in the region. This is also anticipated to propel the development of the Asia Pacific vascular grafts market.
Major participants in the market include LeMagitre Vascular Inc.; Peripheral Vascular Inc.; Shanghai Suokang Medical Implants Co., Ltd; and e Medtronic.
Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/vascular-graft-market